Senescent cells harbour features of the cancer epigenome.
Level 5 - mechanism / opinion, no new human data
In vitro bench laboratory study using human cell lines without clinical human subjects.
PubMed 24270890 · doi:10.1038/ncb2879
What was done
Researchers performed whole-genome single-nucleotide bisulfite sequencing on replicative senescent human cells to assess global DNA methylation patterns and evaluated the localization of the maintenance DNA methyltransferase DNMT1.
What was found
The abstract reports no numerical values. Replicative senescent cells showed widespread DNA hypomethylation predominantly in gene-poor, late-replicating, lamin-associated domains, linked to DNMT1 mislocalization as cells approached senescence. Focal low-level methylation gains were enriched in CpG islands, including cancer-associated genes. This altered methylation profile was largely retained when cells bypassed senescence.
Why it matters
This study demonstrates that the DNA methylome of replicative senescent cells mirrors key epigenetic alterations found in cancer, indicating a mechanistic link where cells escaping senescence may already harbor oncogenic methylation profiles.
Limits
This is purely in vitro cell line research. The abstract lacks quantitative measurements, effect sizes, specific cell line details, and sample sizes. Clinical translation and direct in vivo tumorigenesis were not measured.
Cited by
- supports Aging causes the DNA methylation landscape across the genome to flatten out through gain of methylation at normally unmethylated sites and loss of methylation at normally hypermethylated sites.